NextStage Clinical Research Expands Its Network
NextStage Clinical Research is excited to share that it has opened a new clinical research site in the Kansas City metropolitan area. This expansion brings NextStage's commitment to advancing medical sciences directly to the community, aligning with its mission to facilitate innovative clinical studies.
Enhancing Local Healthcare Opportunities
The newly established facility will engage in Phases Ib through Phase III clinical trials, collaborating with biotech, pharmaceutical, and medical device companies. The focus will be on various specialties including cardiovascular health and orthopedics. This initiative notably increases healthcare accessibility for local patients, promising significant advancements in treatment options.
Leadership Voices Excitement
Julie Rausch, the Interim Chief Operating Officer at NextStage Clinical Research, expressed enthusiasm about the new site, stating, "We are thrilled to expand our presence in Kansas City. Our objective is to expedite medical innovation, ensuring patients have access to the latest therapeutic options. This location represents another step towards that goal."
Commitment to Excellence
NextStage is positioned to deliver groundbreaking research outcomes by aligning with distinguished sponsors and healthcare professionals. The company prides itself on maintaining a focus on patient welfare and safety throughout its trials. Since its inception, NextStage has built a reputation for operational excellence, an essential aspect of its expansion strategy.
Future Prospects
As Co-Founder and CEO Robert Schwing notes, "Our ability to serve more areas and cater to a broader range of therapeutic indications substantially enhances our contribution to the biopharmaceutical industry. By expanding our reach, we can better serve the healthcare needs of our clients and the community as a whole."
About NextStage Clinical Research
NextStage Clinical Research is dedicated to elevating medical knowledge through high-quality clinical trials across diverse therapeutic areas. With operational sites in nine states across the continental United States, the company aims for steady growth, offering a robust network of clinical trial solutions. Prioritizing excellence, NextStage empowers its sites and partners, driving innovations that enhance patient care, one clinical trial at a time.
Frequently Asked Questions
What services does NextStage Clinical Research provide?
NextStage conducts high-quality clinical trials across various therapeutic areas, partnering with biopharmaceutical companies to advance medical science.
Where is the new site located?
NextStage's new clinical research site is located in the Kansas City metropolitan area, enhancing local healthcare opportunities.
What trials will be conducted at the new site?
The site will conduct Phases Ib through Phase III clinical trials across specialties such as cardiovascular and orthopedics.
Who is part of NextStage's leadership team?
The leadership team includes Interim COO Julie Rausch and Co-Founder and CEO Robert Schwing, who drive the company's mission to accelerate medical innovation.
How does NextStage ensure patient safety?
Patient safety is a priority for NextStage, maintained through rigorous research protocols, training, and collaboration with experienced healthcare professionals.
